Evidence map›Paper›PMID 19321938›Full record

ArticleOphthalmic research2009

Blood vessel maturation in human uveal melanoma: spatial distribution of neovessels and mature vasculature.

Yolanda Piña, Colleen M Cebulla, Timothy G Murray, Armando Alegret, Sander R Dubovy, Hinda Boutrid, William Feuer, Lejla Mutapcic, Maria-Elena Jockovich

Open access · bronzeAbstract read
In one paragraph

Article in Ophthalmic research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Analysis of Lysyl Oxidase Expression and Vascular Bed in Human Uveal Melanoma.Bulletin of experimental biology and medicine · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2009
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yolanda PiñaDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Fla 33101, USA.
Colleen M Cebulla
Timothy G Murray
Armando Alegret
Sander R Dubovy
Hinda Boutrid
William Feuer
Lejla Mutapcic
Maria-Elena Jockovich
University of Miami · USOphthalmology Associates (United States) · USMiami Transplant Institute · US

Funding

Shared Equipment ModuleP30EY014801 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Victor L Perez · 2004 to 2026
$12.2M
METALLOPROTEINASES AND FAILURE TO REEPITHELIALIZER01EY012651 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI FINI, M. ELIZABETH · 1999 to 2006
$2.5M
GLOBE CONSERVATION IN TRANSGENIC RETINOBLASTOMAR01EY013629 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MURRAY, TIMOTHY G · 2004 to 2006
$1.0M
NEI NIH HHS P30 EY014801NEI NIH HHS R01 EY012651NEI NIH HHS R01 EY013629NEI NIH HHS R01EY013629NEI NIH HHS R01 EY12651
6 · The paper itself

Abstract

purposeThe aims of this study are (1) to evaluate the spatial distribution of neovessels and mature vessels in human uveal melanoma tumors and (2) to determine whether vessel maturation is associated with the major indicators for poor prognosis.

methodsImmunohistochemical analyses were performed on human tissue specimens from enucleated eyes (n = 14) to assess total vessels, neovessels, mature vessels, and cell proliferation. Tumor morphology was analyzed by hematoxylin and eosin and modified periodic acid-Schiff (PAS) staining.The spatial distribution of neovessels and mature vessels was analyzed by immunohistochemistry, and correlated with major indicators of poor prognosis (i.e., aggressive PAS patterns, epithelioid cytology, mitotic figures, extraocular extension, anterior tumor location, ciliary body involvement, large tumor size, cell proliferation, and angiogenic activity).

resultsNeovesseldensity was greater than mature vessel density in apical (p = 0.17), central (p = 0.036), and peripheral (p = 0.31) regions of the tumors, while mature vessel density was greater than neovessel density in basal areas of the tumor (p = 0.47). This pattern indicated that vessel maturation begins at the base of the tumor and later extends to the peripheral and apical regions. The difference between mature and neovessel densities for the apical (-0.8 +/- 1.9) and central areas (-0.8 +/- 1.3) of the tumor was significantly higher than the difference obtained for the basal area (0.3 +/- 1.6; p = 0.014 and p = 0.012, respectively), indicating a higher density of mature vessels compared to neovessels at the base. Statistical correlations were found between mature vessel density and tumor size (r = 0.48, p = 0.084), cell proliferation (r = 0.62, p = 0.042), and mitotic figures (r = 0.76, p = 0.001).

conclusionsSignificant differences exist in the spatial distribution of mature versus neovessels in human uveal melanoma. Vessel maturation is associated with known clinical and pathologic indicators of poor prognosis (e.g., cell proliferation). Antiangiogenic therapy should be considered for the treatment of ocular malignancies; however, the results of this study indicate that blood vessel maturation heterogeneity may limit the efficacy of vessel targeting agents.

Indexed as

AdolescentAdultAgedAged, 80 and overBiomarkersBlood VesselsEndothelium, VascularEye EnucleationFemaleFluorescent Antibody Technique, IndirectHumansMaleMelanomaMicroscopy, FluorescenceMiddle AgedNeovascularization, PathologicBiomarkers

Identifiers

PMID19321938
PMCPMC3713740
OpenAlexW2071927524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.